Overview
Systematic comparative review searching PubMed from January 2016 through June 2026 for studies examining co-exposure to two or more metals in Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS). The review included 93 unique studies and explicitly compares evidence for mixture effects across the four diseases, asking which metal combinations have been directly documented and whether interaction patterns are disease-specific or shared. This is the first systematic review to structure a cross-disease comparison with mixture statistics as the central evaluation criterion.
Key numbers
93 unique studies: AD 49, PD 38, ALS 19, MS 18, with 31 shared across two or more disease categories. PubMed search date 1 July 2026; publication window January 2016 through June 2026.
Mixture interaction findings by disease:
- AD: combined lead, cadmium, arsenic, and mercury exposure linked to amyloid-beta accumulation and dementia risk. Higher selenium values attenuated the negative association between combined arsenic-cadmium-lead exposure in Chinese older adults.
- PD: manganese-vanadium co-exposure produced more severe dopaminergic damage than either metal alone; manganese was documented to activate the familial PD gene LRRK2.
- ALS: a multi-metal mixture (aluminum, cadmium, fluoride) was associated with a three-fold higher ALS disease risk independent of genetic susceptibility.
- MS: almost no designed mixture studies despite considerable single-metal data; conflicting findings across cohorts; identified as an evidence gap requiring WQS/BKMR studies.
Three general mechanisms identified: competition at shared membrane transporters (notably DMT1), sequestration by metal-binding proteins, and direct synergistic or antagonistic interactions where essential elements modulate toxic-metal handling.
Evidence Fitness
Context only. This is a systematic review of literature from 2016 to 2026, not a primary occurrence or biomonitoring study. It does not report food concentration data or dietary exposure estimates. It characterizes the state of mixture-interaction evidence across four neurodegenerative outcomes and identifies research gaps. Provides mechanistic and epidemiological context for the mixture underprotection synthesis; does not independently quantify dietary exposure risk.
Methods (brief)
Structured PubMed search using four keyword strings, each combining a metal/metalloid term, a mixture/co-exposure term, and a disease term. Zotero for article management. Two reviewers screened titles and abstracts; disagreements resolved by a third reviewer. Studies classified as Direct (formal mixture statistics: WQS, BKMR, quantile g-computation, or multi-arm experiment), Multi-metal (two or more metals measured individually in same sample), Single-metal (mechanistic context), or Review. No pooled meta-analysis conducted; qualitative synthesis.
Implications
Certification: Reinforces the HMT&C multi-analyte panel rationale. The mechanistic evidence for lead-cadmium-arsenic-mercury interactions at shared transporters (DMT1) supports concurrent monitoring of these analytes rather than single-analyte thresholds.
Courses: Excellent overview for a module on mixture toxicology and neurodegeneration. The cross-disease comparison framework helps educators explain why mixture effects may differ by endpoint even for the same metal combination.
App: No food concentration data; not applicable to contamination_profile blocks.
Microbiome: Potential WikiBiome crosswalk thread on gut-brain axis and metals-microbiome-neurodegeneration; not the primary focus of this paper.
Related evidence
- Lead
- Cadmium
- Arsenic, Total
- Mercury, Total
- Manganese
- Single-metal regulatory limits systematically underprotect against dietary heavy-metal exposure
Update history
No substantive edit history is available in this build. The full commit record is available in git.